Enveric Biosciences Stock (NASDAQ:ENVB)
Previous Close
$1.11
52W Range
$1.01 - $134.32
50D Avg
$1.24
200D Avg
$26.66
Market Cap
$2.72M
Avg Vol (3M)
$214.47K
Beta
0.45
Div Yield
-
ENVB Company Profile
Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.